Provista Diagnostics Announces First Patient Enrolled in Prospective, Proof-of-Concept Study of its Protein Biomarker Blood Test to Assess the Presence of Breast Cancer
19 mai 2014 05h00 HE
|
Provista Diagnostics, Inc.
New York, NY, May 19, 2014 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc., a molecular diagnostics company
developing and commercializing proteomic-based diagnostic,
prognostic and monitoring tests...
Provista Diagnostics Announces the Closing of $6.0 Million Financing
16 avr. 2013 12h50 HE
|
Provista Diagnostics, Inc.
Scottsdale, April 16, 2013 (GLOBE NEWSWIRE) -- Provista Diagnostics, Inc. is pleased to
announce the closing of a $6.0 million private round of Series A
Preferred financing on April 10, 2013. As...